The FDA announced on Aug. 27, 2026, that Macleods Pharmaceuticals Limited is recalling Olanzapine Tablets, USP 5 mg due to failed impurity specifications. The recall affects 22,032 bottles distributed nationwide.
How to tell if you have it
- Brand: Macleods
- Product: Olanzapine Tablets, USP 5 mg, 30-count bottle
- NDC: 33342-068-07
- Lot code: BOB22321A
- Expiration date: 07-31-2027
- Quantity: 22,032 bottles
The hazard
According to the FDA, the recalled Olanzapine Tablets contain organic and unspecified impurities above specification. The agency classified this as a Class III recall.
Context
GovInfoNow's records show other recent recalls of similar products include Somerset Therapeutics Dexamethasone Injection Recall: Impurities May Cause Harm (2026-02-04), Ajanta Pharma Fluphenazine Tablets Recall: Impurity Risk in 100-Count Bottles (2026-08-25), and Unichem Bisoprolol/Hydrochlorothiazide Tablets Recall: N-Nitroso Impurity Risk (2026-01-21).